David Werwath, MD
Emergency Medicine · Virginia Beach, VANPI 1164495792
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 270 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 37 manufacturers, the largest accounting for just 21.4% — the pattern of someone who eats at a lot of different presentations. Among emergency medicine clinicians in VA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 270 payments — averaging $18.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$1K
- Takeda Pharmaceuticals U.S.A., Inc.$339
- Amgen$335
- AbbVie$332
- GSK$252
- Pfizer$250
- plus $2K from 31 others
What the payments were for
- Food & beverage$4,986100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 50 | $1,068 |
| Takeda Pharmaceuticals U.S.A., Inc. | 19 | $339 |
| Amgen | 21 | $335 |
| AbbVie | 14 | $332 |
| GSK | 13 | $252 |
| Pfizer | 16 | $250 |
| Lilly USA, LLC | 15 | $242 |
| Novo Nordisk | 15 | $232 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 13 | $191 |
| Kowa Pharmaceuticals America, Inc. | 12 | $165 |
| Teva Pharmaceuticals USA, Inc. | 5 | $159 |
| Exact Sciences | 7 | $153 |
| Esperion Therapeutics, Inc. | 6 | $126 |
| Novartis | 6 | $102 |
| Biohaven Pharmaceutical Holding Company Ltd. | 5 | $93 |
| Biohaven Pharmaceuticals, Inc. | 6 | $92 |
| Irhythm Technologies, Inc. | 4 | $91 |
| Merck | 5 | $86 |
| Sumitomo Pharma America, Inc. | 4 | $79 |
| Antares Pharma, Inc. | 3 | $62 |
| Bioventus LLC | 3 | $52 |
| Boehringer Ingelheim | 3 | $51 |
| Sunovion Pharmaceuticals Inc. | 3 | $48 |
| Lundbeck LLC | 2 | $43 |
| Supernus Pharmaceuticals, Inc. | 3 | $35 |
| E.r. Squibb & Sons, L.L.C. | 2 | $32 |
| Bausch Health US, LLC | 2 | $32 |
| Genentech USA, Inc. | 2 | $32 |
| Johnson & Johnson | 2 | $32 |
| Eisai Inc. | 2 | $30 |
| Astellas Pharma US Inc | 1 | $26 |
| Azurity Pharmaceuticals, Inc. | 1 | $23 |
| Neurelis, Inc. | 1 | $22 |
| Vertex | 1 | $21 |
| Almatica Pharma LLC | 1 | $21 |
| Ultragenyx Pharmaceutical Inc. | 1 | $19 |
| Neos Therapeutics, LP | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,986 in reported general payments places this provider in the 95th percentile of 1,279 emergency medicine providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| FarxigaDapagliflozin Propanediol | 82 | $80,860 |
| OzempicSemaglutide | 62 | $67,701 |
| EliquisApixaban | 82 | $65,769 |
| OtezlaApremilast | 11 | $53,139 |
| XareltoRivaroxaban | 36 | $36,673 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 21 | $25,360 |
| Repatha SureclickEvolocumab | 17 | $18,113 |
| MounjaroTirzepatide | 17 | $17,455 |
| JanuviaSitagliptin Phosphate | 13 | $17,217 |
| EntrestoSacubitril/Valsartan | 17 | $11,799 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 15 | $9,784 |
| MyrbetriqMirabegron | 16 | $7,479 |
| Gabapentin | 181 | $2,299 |
| Levothyroxine Sodium | 193 | $1,797 |
| Rosuvastatin Calcium | 182 | $1,675 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AstraZenecaFarxiga, Breztri Aerosphere | $1,068 | $90,64397 claims |
| Novo NordiskOzempic | $232 | $67,70162 claims |
| PfizerEliquis, Paxlovid | $250 | $67,182101 claims |
| AmgenOtezla | $335 | $53,13911 claims |
| Johnson & JohnsonXarelto | $32 | $36,67336 claims |
| GSKTrelegy Ellipta | $252 | $25,36021 claims |
| Lilly USA, LLCMounjaro | $242 | $17,45517 claims |
| MerckJanuvia | $86 | $17,21713 claims |
| NovartisEntresto | $102 | $11,79917 claims |
| Astellas Pharma US IncMyrbetriq | $26 | $7,47916 claims |
| AbbVieSynthroid | $332 | $1,12422 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,279 emergency medicine providers in Virginia.
Other emergency medicine in Virginia Beach
- Bruce LoVirginia Beach$5K
- James WilsonVirginia Beach$981
- Edward ReadRichmond$402K
- Alex HamidiWilliamsburg$133K
- David BurtCharlottesville$76K
- Marleine ClayMc Lean$71K
- Christopher ThomCharlottesville$52K
- Michelle ClintonRoanoke$42K
- Scott WeirFalls Church$17K
- Clarence KongNorfolk$17K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.